4.6 Article

Diagnostic and Therapeutic Uses of Nanomaterials in the Brain

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 21, Issue 36, Pages 4100-4131

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867321666140815124246

Keywords

Alzheimer's disease; brain tumors; diagnosis; engineered nanomaterials; nanoscience; nanotechnology; Parkinson's disease

Funding

  1. Spanish Ministry of Science and Innovation [SAF2010-15547]
  2. COST Action [TD1004]
  3. University of Navarra (FUN)

Ask authors/readers for more resources

Nanomedicine has recently emerged as an exciting tool able to improve the early diagnosis and treatment of a variety of intractable or age-related brain disorders. The most relevant properties of nanomaterials are that they can be engineered to cross the blood brain barrier, to target specific cells and molecules and to act as vehicles for drugs. Potentially beneficial properties of nanotherapeutics derived from its unique characteristics include improved efficacy, safety, sensitivity and personalization compared to conventional medicines. In this review, recent advances in available nanostructures and nanomaterials for brain applications will be described. Then, the latest applications of nanotechnology for the diagnosis and treatment of neurological disorders, in particular brain tumors and neurodegenerative diseases, will be reviewed. Recent investigations of the neurotoxicity of the nanomaterial both in vitro and in vivo will be summarized. Finally, the ongoing challenges that have to be meet if new nanomedical products are to be put on the market will be discussed and some future directions will be outlined.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available